AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
20.31
+0.34 (1.70%)
Nov 20, 2024, 4:00 PM EST - Market closed
AnaptysBio Employees
AnaptysBio had 117 employees as of December 31, 2023. The number of employees increased by 21 or 21.88% compared to the previous year.
Employees
117
Change (1Y)
21
Growth (1Y)
21.88%
Revenue / Employee
$488,650
Profits / Employee
-$1,415,880
Market Cap
618.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Varex Imaging | 2,400 |
CureVac | 1,172 |
Phathom Pharmaceuticals | 452 |
Butterfly Network | 225 |
Annexon | 71 |
ABIVAX Société Anonyme | 61 |
Immunome | 55 |
Tectonic Therapeutic | 44 |
ANAB News
- 15 days ago - Anaptys Announces Participation in November and December Investor Conferences - GlobeNewsWire
- 15 days ago - Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Anaptys Announces Participation in September Investor Conferences - GlobeNewsWire
- 3 months ago - AnaptysBio: Top-Line AD Data End Of 2024 Could Be Turning Point - Seeking Alpha
- 3 months ago - Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering - GlobeNewsWire
- 3 months ago - Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst - Benzinga
- 6 months ago - Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire